Windtree Therapeutics Reports Third Quarter 2024 Financial

9 hours ago · Select Third Quarter 2024 Financial Results. For the third quarter ended September 30, 2024, the Company reported an operating loss of $4.7 million, which was comparable to …

CouponFollow Extension

$4
OFF

Windtree Therapeutics Reports Third Quarter 2024 Financial

1 day from now

9 hours ago · Select Third Quarter 2024 Financial Results. For the third quarter ended September 30, 2024, the Company reported an operating loss of $4.7 million, which was comparable to …

globenewswire.com

$2
OFF

Windtree Therapeutics Inc. (WINT) Reports Earnings - Quartz

1 day from now

2 days ago · The filing includes financial statements for the quarter, reporting a net loss of $2.7 million and $4.6 million for the three and nine months ended September 30, 2024, …

qz.com

$4
OFF

Windtree Therapeutics Reports Third Quarter 2024 Financial …

1 day from now

9 hours ago · For the third quarter ended September 30, 2024, the Company reported an operating loss of $4.7 million, which was comparable to an operating loss of $4.7 million in the …

businessinsider.com

$10
OFF

MediWound Reports Third Quarter 2024 Financial Results And

1 day from now

1 day ago · Net Loss: Net loss for the third quarter of 2024 was $10.3 million, or $0.98 per share, compared to a net loss of $2.2 million, or $0.24 per share, in the third quarter of 2023. This …

globenewswire.com

81%
OFF

Axsome Therapeutics Reports Third Quarter 2024 Financial Results …

1 day from now

Nov 12, 2024 · Third Quarter 2024 Financial Highlights Total net product revenue for the third quarter of 2024 was $104.8 million, representing 81% year-over-year growth. Total net product …

yahoo.com

4%
OFF

New Jersey MarketBeats | US | Cushman & Wakefield

1 day from now

Oct 8, 2024 · In New Jersey industrial market, leasing grew by 19.4% quarter-over-quarter (QOQ), totaling 8.0 million square feet (msf) and bringing the year-to-date (YTD) total to 21.2 msf by …

cushmanwakefield.com

FAQs about Windtree Therapeutics Reports Third Quarter 2024 Financial Coupon?

What did Axsome Therapeutics do in Q3 2024?

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced financial results for the third quarter of 2024 and provided a general business update. ...

What did compass Therapeutics do in third quarter 2024?

BOSTON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today reported third quarter 2024 financial results and provided a business update. ...

What is included in our operating loss for the third quarter 2024?

Included in our operating loss for the third quarter of 2024 is $2.2 million related to the change in fair value of our common stock warrant liability and $0.7 million in expenses related to the two private placements completed in July 2024 which were allocated to the warrants issued in those transactions and expensed immediately. ...